Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares Outstanding
Ratios

Enanta Pharmaceuticals (ENTA) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q3 2025 value amounting to $21.4 million.

  • Enanta Pharmaceuticals' Shares Outstanding rose 91.06% to $21.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.4 million, marking a year-over-year increase of 91.06%. This contributed to the annual value of $21.4 million for FY2025, which is 91.06% up from last year.
  • According to the latest figures from Q3 2025, Enanta Pharmaceuticals' Shares Outstanding is $21.4 million, which was up 91.06% from $21.4 million recorded in Q2 2025.
  • Enanta Pharmaceuticals' Shares Outstanding's 5-year high stood at $21.4 million during Q3 2025, with a 5-year trough of $20.2 million in Q1 2021.
  • Over the past 5 years, Enanta Pharmaceuticals' median Shares Outstanding value was $21.1 million (recorded in 2023), while the average stood at $20.9 million.
  • Its Shares Outstanding has fluctuated over the past 5 years, first surged by 273.25% in 2022, then skyrocketed by 59.84% in 2024.
  • Over the past 5 years, Enanta Pharmaceuticals' Shares Outstanding (Quarter) stood at $20.5 million in 2021, then grew by 1.84% to $20.9 million in 2022, then grew by 1.3% to $21.2 million in 2023, then grew by 0.84% to $21.3 million in 2024, then grew by 0.25% to $21.4 million in 2025.
  • Its Shares Outstanding was $21.4 million in Q3 2025, compared to $21.4 million in Q2 2025 and $21.4 million in Q1 2025.